Veytics Intelligence
2026-09-25 · Marketwatch

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.